Carlos A. Estrada

Carlos Estrada practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Carlos Estrada's NPI, 1558305714, was assigned on June 16, 2006. Carlos Estrada holds Alabama license 17928.

Carlos Estrada's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Carlos Estrada's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. The medical group on file is UAB Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Carlos Estrada practices. Vendor and product names are available with a free account.

Internal medicine is Carlos Estrada's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Carlos Estrada is licensed in Alabama.

CMS data shows 35 Medicare services from Carlos Estrada across 2 procedure codes in 2024, for 21 Medicare patients. Medicare paid $1,425 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 21 Medicare patients who saw Carlos Estrada in 2024. 75% of them have high blood pressure, and 62% have high cholesterol. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Carlos Estrada's median patient age at 61, with 38% women.

In 2024, Carlos Estrada wrote 148 Medicare Part D claims for 52 patients. 80% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $209 in total drug cost. In 2023, CMS named 82 claims across 5 drugs.

Carlos Estrada accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Carlos Estrada, published from 2012 to 2013. Carlos Estrada's most frequent co-authors are Robert M. Centor, MD, Gustavo R. Heudebert, MD and John William Schleifer, MD.

CMS Open Payments shows 4 general payments to Carlos Estrada from 3 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $125.